Full Text
HP3- INCORPORATING CLINICAL OUTCOMES AND ECONOMIC CONSEQUENCES INTO DRUG FORMULARY DECISIONS- EVALUATION OF 30 MONTHS OF EXPERIENCE

Abstract

Authors

DE Atherly SD Sullivan DS Fullerton LL Sturm

Back to Volume 4, Issue 2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×